Dispatch Bio Announces Clinical Supply and Collaboration Agreement with Bristol Myers Squibb in Solid TumorsBusiness Wire • 11/04/25
Bristol-Myers Squibb: Increased Global Breyanzi Sales Isn't Only Hematological Product GrowthSeeking Alpha • 11/03/25
Biotech is back. Here's why these rallying stocks belong in your portfolio now.Market Watch • 11/03/25
Bristol Myers Squibb Showcases New Long-Term and Real-World Data From Cardiovascular Portfolio at the American Heart Association Scientific Sessions 2025Business Wire • 11/03/25
Bristol Myers' New Treatments Drive Q3 Beat — And The Company's Raising Its OutlookBenzinga • 10/30/25
Bristol-Myers Squibb Q3 Earnings Review: Despite Today's Gains, I See Trouble AheadSeeking Alpha • 10/30/25
10 Ideal 'Safer' Dividend Buys From 38 Of 68 October Graham Value All-Stars (GVAS)Seeking Alpha • 10/30/25
Bristol Myers (BMY) Reports Q3 Earnings: What Key Metrics Have to SayZacks Investment Research • 10/30/25
Bristol Myers Squibb (BMY) Q3 Earnings and Revenues Surpass EstimatesZacks Investment Research • 10/30/25
Uh Oh !! Cathie Wood Predicts “Reality Check” (Sell-off) – 5 High-Yield Dividend Safety Stocks24/7 Wall Street • 10/28/25